Advertisement

Intensive Care Medicine

, Volume 45, Issue 1, pp 128–129 | Cite as

Clarification of errors in Abbas et al.’s conflict of interest narrative review

  • Robert A. Weinstein
Letter

References

  1. 1.
    Abbas M, Pires D, Peters A, Morel CM, Hurst S, Holmes A, Saito H, Allegranzi B, Lucet JC, Zingg W, Harbarth S, Pittet D (2018) Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review. Intensive Care Med.  https://doi.org/10.1007/s00134-018-5361-z Google Scholar
  2. 2.
    Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA (2007) Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 167(19):2073–2079CrossRefPubMedGoogle Scholar
  3. 3.
    Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA et al (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368(6):533–542CrossRefPubMedGoogle Scholar
  4. 4.
    Munoz-Price LS, Hota B, Stemer A, Weinstein RA (2009) Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 30(11):1031–1035CrossRefPubMedGoogle Scholar
  5. 5.
    Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK (2009) Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 30(10):959–963CrossRefPubMedGoogle Scholar
  6. 6.
    Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK (2010) Daily skin cleansing with chlorhexidine did not reduce the rate of central line associated bloodstream infection in a surgical intensive care unit. Intensive Care Med 36(5):854–858CrossRefPubMedGoogle Scholar
  7. 7.
    Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA (2006) Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 166(3):306–312CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature and ESICM 2018

Authors and Affiliations

  1. 1.Chairman Emeritus, Department of Medicine, Cook County Health and Hospitals SystemRush University Medical CenterChicagoUSA

Personalised recommendations